The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Budzinskaia M.V.

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

Age-related macular degeneration

Authors:

Budzinskaia M.V.

More about the authors

Journal: Russian Annals of Ophthalmology. 2014;130(6): 56‑61

Read: 2980 times

Contact the author
Table of contents

AGE-RELATED MACULAR DEGENERATION
AGE-RELATED MACULAR DEGENERATION

To cite this article:

Budzinskaia MV. Age-related macular degeneration. Russian Annals of Ophthalmology. 2014;130(6):56‑61. (In Russ.)

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Mono­cyte telo­mere length as a novel biomarker of macu­lar atro­phy and response to anti-VEGF therapy in age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2025;(6):52-61
Use of fari­cimab in neovascular age-related macu­lar dege­neration and diabetic macu­lar edema in Russia. Resu­lts of the FARWATER retrospective study. Russian Annals of Ophthalmology. 2025;(6):82-91
Resu­lts of the multicenter study “Registry of patients with inhe­rited reti­nal dystrophies caused by confirmed biallelic muta­tions in the RPE65 and RLBP1 genes in Russia (REGINA)”. Report 1. Mole­cular gene­tic characteristics of inhe­rited reti­nal pathologies. Russian Annals of Ophthalmology. 2026;(1):70-78
Resu­lts of the multicenter study “Registry of patients with inhe­rited reti­nal dystrophies caused by confirmed biallelic muta­tions in the RPE65 and RLBP1 genes in Russia (REGINA)”. Report 2. Clinical, social and demo­graphic characteristics of inhe­rited reti­nal pathologies. Russian Annals of Ophthalmology. 2026;(1):79-86
Pote­ntial and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medi­cine. 2025;(7):94-99
Prevalence of low-functioning alle­les of folate cycle genes and their asso­ciation with cardiovascular pathology and a complicated obstetric history in the popu­lation of the Arkhangelsk Region. Labo­ratory Service. 2025;(3):8-13
Amyloidogenesis and neurotrophic dysfunction in age-related macu­lar dege­neration in correlation with Alzheimer’s disease. Russian Journal of Archive of Pathology. 2025;(6):61-68
Coro­naviruses in human pathophysiology: a brief history of the COVID-19 pandemic. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):55-63
Distal 18q dele­tion syndrome (18q-) in a pediatric patient. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):244-248
Single nucleotide poly­morphism of the SLC22A10 gene and the risk of endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2026;(1):5-11
Abstract:

The review provides an update on the pathogenesis and new treatment modalities for neovascular age-related macular degeneration (AMD). The impact of polymorphism in particular genes, including complement factor H (CFH), age-related maculopathy susceptibility 2 (ARMS2/LOC387715), and serine peptidase (HTRA1), on AMD development is discussed. Clinical presentations of different forms of exudative AMD, that is classic, occult, or more often mixed choroidal neovascularization, retinal angiomatous proliferation, and choroidal polypoidal vasculopathy, are described. Particular attention is paid to the results of recent clinical trials and safety issues around the therapy.

Keywords:

age-related macular degeneration
choroidal neovascularization
gene
polymorphism

Authors:

Budzinskaia M.V.

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

Close metadata

References:

  1. WHO/World Health Organization. Age Related Macular Degeneration: Priority eye diseases. [Last accessed on 2011 Feb 6]. Available from:http://www.who.int/blindness/causes/priority/en/index8.html. [Ref list
  2. Amerikanskaya Akademiya Oftal'mologii, Ekspertnyy Sovet po vozrastnoy makulyarnoy degeneratsii, Mezhregional'naya Assotsiatsiya vrachey-oftal'mologov.[Americam Academy of Ophthalmology, Expert council of age-related macular degeneration, Interregional Association of ophthalmologists]. Vozrastnaya makulyarnaya degeneratsiya Oftal'mol. vedomosti ser. Ex libris.[Age-related macular degeneration. Oftalmologicheskie vedomosti.Ser. Ex libris.]. SPb.: "Izdatel'stvo N-L" Ltd., 2009, 84p.
  3. Izmaylov, A.S . In.: A.S. Izmaylov, Balashevich L.I. [Choroidal neovascularization. (diagnosis and treatment): Textbook.]: SPb.. :SPBMAPO; 2001, 38 p. ( In Russ.)
  4. Neroev V.V. Russia's nationwide epidemiological noninvasive study of patients with wet age related macular degeneration. Rossiyskiy oftal'mologicheskiy zhurnal. 2011; 4(2): 4-9. ( In Russ.)
  5. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J., Complement Factor H. Polymorphism in Age-Related Macular Degeneration pp. Science. 2005; 308 (5720): 385-389.
  6. Schaumberg D.A., Christen W.G., Kozlowski P. , Miller D.T., Ridker P.M., Zee R.Y. A prospective assessment of the Y402H variant in complement factor H, genetic variants in c-reactive protein, and risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006; 47 (6): 2336-2340.
  7. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1_CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA. 2005; 102 (20): 7227-7232.
  8. Despriet D.D., Klaver C.C., Witteman J.C., Bergen A.A., Kardys I., de Maat M.P., Boekhoorn S.S., Vingerling J.R., Hofman A., Oostra B.A., Uitterlinden A.G., Stijnen T., van Duijn C.M., de Jong P.T. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006; 296 (3): 301-309.
  9. Budzinskaya M.V., Pogoda T.V., Generozov E.V., Chikun E.A., Shchegoleva I.V., Kazaryan E.E., Galoyan N.S. Influence of genetic mutations on clinical presentation of subretinal neovascularization. Report 1: the impact of CFH and IL-8 genes polymorphism. Vestnik oftal'mologii. 2011; 127(4): 3-8. ( In Russ.)
  10. Budzinskaya M.V., Pogoda T.V., Strelkova I.D., Chikun E.A., Shchegoleva I.V., Kazaryan E.E., Galoyan N.S. Influence of genetic mutations on clinical presentation of subretinal neovascularization. Report 2: the impact of HTRA and VEGF genes polymorphism. Vestnik oftal'mologii. 2011; 127(4): 9-16. ( In Russ.)
  11. Magnusson K.P., Duan S., Sigurdsson H., Petursson H., Yang Z., Zhao Y., Bernstein P.S., Ge J., Jonasson F., Stefansson E., Helgadottir G., Zabriskie N.A., Jonsson T., Björnsson A., Thorlacius T., Jonsson P.V., Thorleifsson G., Kong A., Stefansson H., Zhang K., Stefansson K., Gulcher J.R. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 2006; 3 (1): 5.
  12. Thakkinstian A.1., Han P., McEvoy M., Smith W., Hoh J., Magnusson K., Zhang K., Attia J. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum. Mol. Genet. 2006; 15 (18): 2784-2790.
  13. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. USA. 2006; 103 (46): 17456-17461.
  14. Yang Z.1., Tong Z., Chen Y., Zeng J., Lu F., Sun X., Zhao C., Wang K., Davey L., Chen H., London N., Muramatsu D., Salasar F., Carmona R., Kasuga D., Wang X., Bedell M., Dixie M., Zhao P., Yang R., Gibbs D., Liu X., Li Y., Li C., Li Y., Campochiaro B., Constantine R., Zack D.J., Campochiaro P., Fu Y., Li D.Y., Katsanis N., Zhang K. Genetic and functional dissection of HTRA1 and LOC387715 in age-related mamacular degeneration. PLos Genetics. 2010; 6 (2): 1000836.
  15. Nitoda E.1., Koutsilieris M., Brouzas D., Koutsandrea C., Philippou A., Ladas D., Moschos M.M. Correlation of platelet activating factor and age-related macular degeneration. Expert. Opin. Ther. Targets. 2014; 31: 1-11.
  16. Yannuzzi L.A., Negrão S., Iida T., Carvalho C., Rodriguez-Coleman H., Slakter J., Freund K.B., Sorenson J., Orlock D., Borodoker N. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001; 21 (5): 416-434.
  17. Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nihon Ganka Gakkai Zasshi. 2005; 109 (7): 417-427.
  18. Trishmann M., Bitti S., Nolan D.M., Khens Kh.V., Kheymes B., Ostermann U., Fobker M., Paulekkhoff D. Optical density of macular pigment and plasmatic concentrations of caratinoids, they composed of, change after food supplement administration with luteinum and zeaxanthine in luna study. Oftal'mologiya v Belarusi. 2009; 2: 30-49. ( In Russ.)
  19. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013; 309 (19): 2005-2015.
  20. Chew E.Y.1, Clemons T.E., Agrón E., Sperduto R.D., Sangiovanni J.P., Kurinij N., Davis M.D.; Age-Related Eye Disease Study Research Group. Long-term effects of vitamins C and E, &Bgr;-carotene, and zinc on age-related macular degeneration: AREDS report No 35. Ophthalmology. 2013; 120 (8): 1604-1611.
  21. Bernstein P.S., Ahmed F., Liu A., Allman S., Sheng X., Sharifzadeh M., Ermakov I., Gellermann W. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center. Invest. Ophthalmol. Vis. Sci. 2012; 53 (10): 6178-6186.
  22. Brown D.M., Kaiser P.K., Michels M., Soubrane G., Heier J.S., Kim R.Y., Sy J.P., Schneider S., ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 2006; 355 (14): 1432-1444.
  23. Heier J.S., Brown D.M., Chong V., Korobelnik J.F., Kaiser P.K., Nguyen Q.D., Kirchhof B., Ho A., Ogura Y., Yancopoulos G.D., Stahl N., Vitti R., Berliner A.J., Soo Y., Anderesi M., Groetzbach G., Sommerauer B., Sandbrink R., Simader C., Schmidt-Erfurth U., VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012; 119 (12): 2537-2548.
  24. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group1, Martin D.F., Maguire M.G., Fine S.L., Ying G.S., Jaffe G.J., Grunwald J.E., Toth C., Redford M., Ferris F.L. 3rd. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results. Ophthalmology. 2012; 119 (7): 1388-1398.
  25. Chakravarthy U., Harding S.P., Rogers C.A., Downes S.M., Lotery A.J., Culliford L.A., Reeves B.C., IVAN study investigators. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet. 2013; 382 (9900): 1258-1267.
  26. Avery R.L., Castellarin A.A., Steinle N.C., Dhoot D.S., Pieramici D.J., See R., Couvillion S., Nasir M.A., Rabena M.D., Le K., Maia M., Visich J.E. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br. J. Ophthalmol. 2014. Pii: bjophthalmol-2014-305252. Doi: 10.1136/bjophthalmol-2014-305252.
  27. Egorov E.A., Romanenko I.A. Age-related macular degeneration. The problems of pathogenesis, diagnostics and therapy. RMZh. Klinicheskaya oftal'mologiya. 2009; 10(1): 42-45. ( In Russ.)
  28. Panova I.E., Tonkikh N.A., Prokop'eva M.Yu., Bukhtiyarova N.V. Age-related macular degeneration with neovascular answer: peculiarities of clinical course, characteristics of cellular immunity. Vestnik Orenburgskogo gosudarstvennogo universiteta. 2004; S: 246-248. ( In Russ.)
  29. Alpatov S.A., Shchuko A.G., Urneva E.M., Malyshev V.V. Vozrastnaya Makulyarnaya Degeneratsiya. Ser. Biblioteka vracha spetsialista. [Age-related macular degeneration. Ser. The library of medical specialist.] Moscow.: Editorial group "GEOTAR-Media", Ltd. ; 2010, 112.
  30. Mirzabekova K.A. Age-related macular degeneration: prevention and treatment. A review. Oftal'mologiya. 2014; 11(2): 4-8. ( In Russ.).
  31. Budzinskaya M.V., Gurova I.V. Subretinal neovascular membrane in age-related macular degeneration. Vestnik oftal'mologii. 2006; 122(4) : 49-54.( In Russ.)
  32. Avetisov S.E., Mamikonyan V.R., Surguch V.K., Sdobnikova S.V. Antiangiogenic therapy for choroidal neovascularization induced by age-related macular degeneration (preliminary communication). Vestnik oftal'mologii. 2009; 125(6): 3-7. ( In Russ.)
  33. Neroev V.V., Kiseleva T.N., Ryabina M.V., Karapetyan L.V., Ramazanova K.A. Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration. Oftal'mologiya. 2013; 10(2): 38-43. ( In Russ.)
  34. Panova I.E., Prokop'eva M.Yu., Avdeeva O.N., Reznitskaya O.V. Clinical and instrumental monitoring in evaluation of effectiveness of different neovascular age-related macular degeneration treatment varieties. Vestnik Orenburgskogo gosudarstvennogo universiteta. 2011; 14: 292-294. ( In Russ.)
  35. Hassenstein A., Meyer C.H. Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography - a review. Clin. Exper. Ophthalmol. 2009; 37 (1): 130-143.
  36. Panova I.E., Nikitina E.R., Prokop'eva M. Spectral optical coherence tomography for evaluation of early and intermediate stages of age-related macular degeneration. RMZh. Klinicheskaya oftal'mologiya. 2010; 11(1): 8-11. ( In Russ.)
  37. Sheludchenko V.M . Modern trends in the development of functional methods of research in ophthalmology. Vestnik oftal'mologii. 2006; 122(1): 51-54. ( In Russ.)
  38. Sheludchenko V.M . Introduction of the retinal electrical biopotential into multifocal analysis. Vestnik oftal'mologii. 2009; 125(1): 8-12. ( In Russ.)
  39. Sheludchenko V.M., Ronzina I.A., Sheremet N.L., Smirnova T.V., Kazaryan E.E. Capabilities of modern methods of electrophysiological analysis in diseases of visual analyzer. Vestnik oftal'mologii. 2013; 129(5): 43-52. ( In Russ.)
  40. Avetisov S.E., Budzinskaya M.V., Kazaryan E.E., Gurova I.V. Diagnostic value of lifetime retinal morphometry in patients with subretinal neovascularization. Vestnik oftal'mologii. 2007;123(1): 3-7. ( In Russ.)
  41. Regillo C.D. Lampalizumab (anti-factor D) in patients with geography atrophy: the MAHALO phase 2 results. Paper presented at: the 2013 Annual Meeting of the American Academy of Ophthalmology; November 16-19, 2013; New Orleans, LA.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.